PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 12926

Fosfomycin: Absorption and excretion.

K Shimizu
View original source ↗Export metadata ↓

Abstract

Summarized results of absorption and excretion of fosfomycin after oral and intravenous administration obtained from hospitals and institutions in Japan are reported. Fosfomycin was rapidly absorbed and excreted from the urine once it was distributed, the 6-hour urinary recovery reaching about 20% in the case of oral administration and 90% in the case of intravenous injection. These phenomena are almost the same as those previously published. Higher concentration was noticed in the kidney, which gradually decreased according to the fall of the blood level. The blood level reached its maximum of about 3 mug/ml after oral administration to adults at a dose of 500 mg.

Explore related subjects

Administration, OralAnimalsAnti-Bacterial AgentsBicarbonatesFosfomycinHumansHydrogen-Ion ConcentrationInjections, IntravenousKidneyRabbitsTime FactorsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K Shimizu. 1977. Fosfomycin: Absorption and excretion.. https://doi.org/10.1159/000222042

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2004

An integrated reverse functional genomic and metabolic approach to understanding orotic acid-induced fatty liver.

In functional genomics, DNA microarrays for gene expression profiling are increasingly being used to provide insights into biological function or pathology. To better understand the significance of the multiple transcriptional changes across a time period, the temporal changes in phenotype must be described. Orotic acid-induced fatty liver disease was investigated at the transcriptional and metabolic levels using microarrays and metabolic profiling in two strains of rats. High-resolution 1H-NMR spectroscopic analysis of liver tissue indicated that Kyoto rats compared with Wistar rats are predisposed to the insult. Metabolite analysis and gene expression profiling following orotic acid treatment identified perturbed metabolic pathways, including those involved in fatty acid, triglyceride, and phospholipid synthesis, beta-oxidation, altered nucleotide, methyl donor, and carbohydrate metabolism, and stress responses. Multivariate analysis and statistical bootstrapping were used to investigate co-responses with transcripts involved in metabolism and stress responses. This reverse functional genomic strategy highlighted the relationship between changes in the transcription of stearoyl-CoA desaturase 1 and those of other lipid-related transcripts with changes in NMR-derived lipid profiles. The results suggest that the integration of 1H-NMR and gene expression data sets represents a robust method for identifying a focused line of research in a complex system.

Administration, Oral↗
PubMed2004

Accumulation of dietary cadmium (Cd) in rabbit tissues and excretions: a comparison of lettuce amended with soluble Cd salt and lettuce with plant-incorporated Cd.

Quantifying the transfer of Cd from foods to mammalian target organs is key to estimating the health risk from this exposure; however, the bioaccumulation of Cd from foods is modified by many dietary components. Studies of dietary Cd absorption would be simpler if it were known that Cd added to foods as a soluble salt was as bioavailable as Cd incorporated during growth of the food species. Rabbits were fed, for 16 d, fresh lettuce containing cadmium incorporated into the lettuce during growth or added to the lettuce before feeding, or lettuce with no Cd but soluble Cd administered to the animals by gavage. There was a marked positive relationship between increased Cd dose and its accumulation in kidney; the slopes for the gavage and added treatments were not clearly different from the incorporated treatment; liver data were highly variable. In a 10-wk study of Cd-incorporated and -amended lettuce diets, for the incorporated and control diets there was less Cd accumulation in the kidneys, but not liver, per unit cumulative dose, than for the amended diet. Cd accumulation in the small intestine and Cd concentration in feces, both per unit daily dose, were smaller for the incorporated than for the control and amended diets; Cd concentrations in bile, urine, and serum, per unit daily dose, were higher in the control diet than values in the amended diet, which were higher than the incorporated diet. These differences could not be accounted for by variation in Fe or Zn contents of the diets. Thus, data suggest that Cd-amended diets overestimate bioaccumulation in kidney, an important target organ, by up to one-third, and that studies of short duration are not adequate to evaluate Cd bioavailability from food.

Administration, Oral↗
PubMed2004

Expression and function of PPARgamma in rat placental development.

Peroxisome proliferator-activated receptor (PPAR) gamma is a nuclear receptor known to regulate adipogenesis. Deletion of the PPARgamma gene in the mouse results in death by embryonic day 10.0 (E10.0) due to the failure of establishment of a labyrinth layer in the placenta, which suggests that PPARgamma is involved in trophoblast differentiation. To define PPARgamma function further in placental development, the expression and localization of the PPARgamma gene in the rat placenta was investigated. RT-PCR analysis shows the presence of PPARgamma mRNA in the placenta of day 11 of pregnancy (d11). The expression level is higher at d13 and then later decreased. Immunohistochemistry detects both PPARgamma and its putative intrinsic ligand, 15-deoxy-Delta(12,14)-prostaglandin J(2), in the trophoblast of layer I which lined the maternal sinus. Oral administration of troglitazone, an agonist of PPARgamma, to pregnant rats between d9 and d11 increases the expression level of PPARgamma in the placenta and reduces the mortality of the fetuses by half. These results suggest that PPARgamma is required not only for trophoblast differentiation but also trophoblast maturation to establish maternal-fetal transport.

Administration, Oral↗